Search Within

Hematologic Malignancies Research

Formats
  1. Journal Article (1545)
  2. Meeting Abstract (1260)
  3. Review (76)
  4. Editorial (35)
  5. Book Section (32)
  6. Research Letter (26)
  7. Conference Paper (15)
  8. Correspondence (8)
  9. Guidelines (4)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3005)
  2. GSK Faculty (2450)
  3. Department of Medicine (2318)
  4. Hematologic Malignancies, Division of (2120)
  5. Sloan Kettering Institute Faculty (2052)
  6. Molecular Pharmacology and Chemistry Program Faculty (1632)

More Groups

People
  1. Michel Sadelain (586)
  2. David Scheinberg (502)
  3. Alexander Lesokhin (381)
  4. Carl Landgren (336)
  5. Renier Brentjens (286)
  6. Gabriela Chiosis (281)

More People

Years
  1. 2025 (64)
  2. 2024 (131)
  3. 2023 (175)
  4. 2022 (126)
  5. 2021 (154)
  6. 2020 (173)

More Years

Publications
  1. Blood (660)
  2. Cancer Research (117)
  3. Journal of Clinical Oncology (112)
  4. Clinical Lymphoma, Myeloma and Leukemia (84)
  5. Biology of Blood and Marrow Transplantation (80)
  6. Molecular Therapy (68)

More Publications

Publishers
  1. American Society of Hematology (700)
  2. Nature Publishing Group (375)
  3. Elsevier Inc. (291)
  4. American Association for Cancer Research (245)
  5. American Society of Clinical Oncology (116)
  6. Cell Press (116)

More Publishers

Results (3005)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Generation of novel single cell-derived engineered master pluripotent cell line as a renewable source for off-the-shelf TCR-less CAR T cells in support of first-of-kind clinical trial
    Meeting Abstract

    Abujarour, R.; Lai, Y. S.; Pribadi, M.; Lee, T.; Robinson, M.; Ruller, C.; Van der Stegen, S.; Wang, X.; Stefanski, J.; Zhen, J.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Ngai, D. A.; McGee, E.; Chintala, N. K.; Messinger, J. C.; Vincent, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers
    Meeting Abstract

    Osmanbeyoglu, H. U.; Shimizu, F.; Rynne-Vidal, A.; Yeung, T. L.; Jelinic, P.; Mok, S. C.; Chiosis, G.; Levine, D. A.; Leslie, C.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia
    Meeting Abstract

    McNeer, N.; Philip, J.; Geiger, H.; Ries, R. E.; Lavallee, V. P.; Walsh, M.; Shah, M.; Arora, K.; Emde, A. K.; Robine, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Does donor kir-genotype impact outcome after unrelated hematopoietic stell cell transplantation for myelodysplastic syndromes or secondary acute myeloid leukemia?
    Meeting Abstract

    Schetelig, J.; Baldauf, H.; Koster, L.; Kuxhausen, M.; Heidenreich, F.; de Wreede, L. C.; Spellman, S.; Carolin, M.; Lange, V.; van Gelder, M.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Conditioning prior to CD19-specific CAR (19-28Z) T cells predicts response and survival in pediatric relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K.; Margossian, S.; Kernan, N.; Prockop, S.; Boulad, F.; Cancio, M.; Szenes, V.; Kung, A.; Boelens, J. J.; O'Reilly, R.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Prediction of toxicity in R/R DLBCL treated with Axicabtagene Clioleucel (19-28z CAR T)
    Meeting Abstract

    Kotani, H.; Faramand, R.; Lee, S. B.; Yu, B.; Morrissey, D.; Locke, F. L.; Jain, M. D.; Chavez, J. C.; Wang, X.; Mishra, A.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Hematologic toxicities of apparent immune-related origins
    Book Section

    Chen, G. L.; Robert, C.; Lesokhin, A. M.
    In Ernstoff, M. S.; Puzanov, I.; Robert, C.; Diab, A.; Hersey, P. (Eds.) SITC's Guide to Managing Immunotherapy Toxicity (2019)

    Fulltext@MSK | Save
  • Altered nuclear export signal recognition as a driver of oncogenesis
    Journal Article

    Taylor, J.; Sendino, M.; Gorelick, A. N.; Pastore, A.; Chang, M. T.; Penson, A. V.; Gavrila, E. I.; Stewart, C.; Melnik, E. M.; Herrejon Chavez, F.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • m(6)A RNA methylation maintains hematopoietic stem cell identity and symmetric commitment
    Journal Article

    Cheng, Y.; Luo, H.; Izzo, F.; Pickering, B. F.; Nguyen, D.; Myers, R.; Schurer, A.; Gourkanti, S.; Brùˆning, J. C.; Vu, L. P.; more...
    Cell Reports (2019)

    Fulltext@MSK | Save